• A 20-year study of autoimmune polyendocrine syndrome type II and III in Taiwan
• A Case of Autoimmune Poly Glandular Glandular Syndrome Type 2 (Schmidt's Syndrome)
• A case of multiple endocrine neoplasia syndrome type 2A combined with autoimmune polyendocrine syndrome type Ⅲ
• A case report of anti-GAD65 antibody-positive autoimmune encephalitis in children associated with autoimmune polyendocrine syndrome type-II and literature review
• A novel missense mutation in the AIRE gene underlying autoimmune polyglandular syndrome type 1
• A partial form of AIRE deficiency underlies a mild form of autoimmune polyendocrine syndrome type 1
• A Rare Case of Autoimmune Enteropathy Associated with Autoimmune Hepatitis
• Alopecia areata and occurrence of vitiligo and hypothyroidism in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy patients
• An 11-year-old girl with Autoimmune Polyglandular Syndrome (APS) type 2: a case report and review of literature
• Analysis of a series of Italian APECED patients with autoimmune hepatitis and gastro-enteropathies
• Analysis of the AIRE Gene Promoter in Patients Affected by Autoimmune Polyendocrine Syndromes
• APECED and the place of AIRE in the puzzle of the immune network associated with autoimmunity
• APECED Rash as the First Manifestation of APECED Syndrome
• Association of Aortic Stiffness and Pressure Pulsatility With Noninvasive Estimates of Hepatic Steatosis and Fibrosis: The Framingham Heart Study
• Association of latent autoimmune diabetes of adults with type 3 polyglandular autoimmune syndrome-a diagnostic challenge
• Autoimmune adrenal insufficiency in children: a hint for polyglandular syndrome type 2?
• Autoimmune amelogenesis imperfecta in patients with APS-1 and coeliac disease
• Autoimmune enteropathy complicated with primary biliary cholangitis
• Autoimmune polyendocrine syndrome in adults. Focus on rheumatological aspects of the problem: A review
• Autoimmune polyglandular syndrome type 3 diagnosed with cerebral venous sinus thrombosis: a case report
• Autoimmune polyglandular syndrome type 4: experience from a single reference center
• Autoimmune polyglandular syndrome with shock and high anion gap metabolic acidosis
• Autoimmune regulator (Aire) deficiency results in reduced memory CD8⁺ T cells after Listeria monocytogenes infection in a murine model
• Background rates for severe cutaneous reactions in the US: Contextual support for safety assessment of COVID-19 vaccines and novel biologics
• Bone Tissue Evaluation Indicates Abnormal Mineralization in Patients with Autoimmune Polyendocrine Syndrome Type I: Report on Three Cases
• Challenges in autoimmune polyendocrine syndrome type 2 with the full triad induced by anti-programmed cell death 1: a case report and review of the literature
• Clinical characteristics and management of autoimmune enteropathy in children: case reports and literature review
• Clinical manifestations, diagnosis and long-term prognosis of adult autoimmune enteropathy: Experience from Peking Union Medical College Hospital
• Codetections of Other Respiratory Viruses Among Children Hospitalized With COVID-19
• Comparison of bivalent and monovalent SARS-CoV-2 variant vaccines: the phase 2 randomized open-label COVAIL trial
• COVID-19 Vaccine Efficacy in Participants With Weakened Immune Systems From 4 Randomized Controlled Trials
• Discovery of a Novel DYRK1A Mutation (c.524del) in Intellectual Development Disorder Autosomal Dominant 7 (MRD7): A Comprehensive Case Analysis
• Dysregulated germinal center reaction with expanded T follicular helper cells in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy lymph nodes
• FOXP3 deficiency, from the mechanisms of the disease to curative strategies
• Human autoantibodies neutralizing type I IFNs: From 1981 to 2023
• Identification of unstable regulatory and autoreactive effector T cells that are expanded in patients with <em>FOXP3</em> mutations
• Immunogenicity of the BA.1 and BA.4/BA.5 Severe Acute Respiratory Syndrome Coronavirus 2 Bivalent Boosts: Preliminary Results From the COVAIL Randomized Clinical Trial
• Immunomodulators for immunocompromised patients hospitalized for COVID-19: a meta-analysis of randomized controlled trials
• Increased frequency of microalbuminuria in patients with type 3 autoimmune polyglandular syndrome (APS) compared to isolated autoimmune type 1 diabetes mellitus: A real-life study
• IPEX syndrome from diagnosis to cure, learning along the way
• JAK Inhibition Immunotherapy for APS-1
• Learning the Autoimmune Pathogenesis Through the Study of Aire
• Leber congenital amaurosis as the initial and essential manifestation in a Chinese patient with autoimmune polyglandular syndrome Type 1
• Long-term remission of candidiasis with fermented lingonberry mouth rinse in an adult patient with APECED
• Magnetic Resonance Imaging Measures to Track Atrophy Progression in Progressive Supranuclear Palsy in Clinical Trials
• Neurological Diseases and Prevalence of Antineuronal Antibodies in Patients with Autoimmune Polyendocrine Syndrome Type 1 - A National Cohort Study
• Novel Insights into the Autoimmunity from the Genetic Approach of the Human Disease
• Ocular features of autoimmune polyendocrinopathy candidiasis ectodermal dystrophy
• Polyendocrine syndromes in dogs
• Progressive Impairment of Prepubertal Growth in Children With APECED
• Pubertal development and hypogonadism in males with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy: a retrospective study
• Recurrent venous thrombosis - an unusual first presentation of autoimmune polyendocrinopathy syndrome type 3B
• Risk of myocarditis and pericarditis after a COVID-19 mRNA vaccine booster and after COVID-19 in those with and without prior SARS-CoV-2 infection: A self-controlled case series analysis in England
• Routine Eyelid Care for Those Without a Rash
• Ruxolitinib Rescues Multiorgan Clinical Autoimmunity in Patients with APS-1
• SARS-CoV-2-induced adrenal crisis in a patient with autoimmune polyglandular syndrome type 1: case report
• Secondary membranous nephropathy associated to autoimmune polyglandular syndrome Type II
• Successful live birth following a short course of glucocorticoid suppression in a patient with autoimmune polyglandular syndrome type 2 and premature ovarian insufficiency: A case report
• Systemic interferon type I and B cell responses are impaired in autoimmune polyendocrine syndrome type 1
• T-cell receptor repertoire analysis of CD4-positive T cells from blood and an affected organ in an autoimmune mouse model
• Targeting GD2-positive Refractory/Resistant Neuroblastoma and Osteosarcoma with Anti- CD3 x Anti-GD2 Bispecific Antibody Armed T cells
• Targeting refractory/recurrent neuroblastoma and osteosarcoma with anti-CD3×anti-GD2 bispecific antibody armed T cells
• Teamwork makes the dream work: functional collaborations between families, scientists, and healthcare providers to drive progress in the treatment of Leigh Syndrome
• The Role of Interferon-gamma in Autoimmune Polyendocrine Syndrome Type 1
• Unusual Manifestations of APECED
• VKH with APECED in a Two-Year-Old Child: A Rare Concomitant Diagnosis in an Unprecedented Age